L-Carnitine-Mediated Tumor Cell Protection and Poor Patient Survival Associated with OCTN2 Overexpression in Glioblastoma Multiforme.

Matthias Alexander Fink Heiko PalandSusann HerzogMarkus GrubeSilke VogelgesangKerstin WeitmannAngela BialkeWolfgang HoffmannBernhard H RauchHenry W S SchroederSandra Bien-Möller

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)

Our data indicate a potential role of the OCTN2/LC system in GBM progression and resistance to therapy, and suggests OCTN2 as a prognostic marker in patients with primary GBM.

Keyphrases

cell therapy
single cell
case report
cell proliferation
electronic health record
transcription factor
big data
stem cells
machine learning
human health
free survival
risk assessment
mesenchymal stem cells
high resolution
deep learning